[1] Pan B, Jinghua Y U, Huang Y,et al. Construction of postoperative prognostic model for primary liver cancer based on SMOTE and machine learning. J Army Med Uni, 2024, 46(19):2236-2240. [2] Tang S, Liu H, Chen P,et al. Prognostic value of AFP-L3 and des-γ-carboxy prothrombin in advanced primary liver cancer treated with sorafenib and transarterial chemoembolization. Am J Transl Res, 2024, 16(9):5004-5010. [3] Bilen MA, Vo BT, Liu Y, et al. Neoadjuvant cabozantinib for locally advanced nonmetastatic clear cell renal cell carcinoma: a phase 2 trial. Nat Cancer, 2025,6(3):432-444. [4] 中华人民共和国国家卫生健康委员会医政司.原发性肝癌诊疗指南(2024年版).中华肝脏病杂志,2024,32(7):581-630. [5] LiM, Yu B, Yang H,et al. Comparative efficacy of non-pharmacological interventions on anxiety, depression, sleep disorder, and quality of life in patients with liver transplantation: A systematic review and network Meta-analysis. J Clin Nurs, 2025, 34(6):1993-2010. |